Radiofrequency Therapy Systems, Tissue Ablation, Prostatic

Definition : Tissue ablation radio-frequency (RF) therapy systems designed to ablate regions of the prostate. These systems consist of an RF generator; a catheter to be introduced into the prostatic urethra or rectum, sometimes with capability to deploy needlelike electrodes from its tip; sleeves to prevent the exposure of untargeted tissue; thermocouples to record ablation and prosthetic temperature; and a neutral electrode that is placed on the body surface. Prostatic ablation RF systems are used for treating benign prostatic hyperplasia and cancer of the prostate.

Entry Terms : "Transurethral Thermotherapy Systems" , "Prostatic Ablation Systems"

UMDC code : 18805

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Medtronic Inc

Company Type: Parent

At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible.

NxThera Inc

Company Type: Parent

Urologix Inc

Company Type: Parent

Urologix, Inc., based in Minneapolis, Minnesota develops, manufactures and markets minimally invasive urological treatment products. Urologix has developed and offers non-surgical, catheter-based treatments that use proprietary microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix is a leader in less invasive technology for the BPH treatment, with more than 225,0001 patients treated to date.

1-3 of 3 Match(es).


Sign Up for Free e-newsletters

Medical Product Guide OBG Management Product Zone